Picture of L&K Biomed Co logo

156100 L&K Biomed Co Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m-0.78%
3m+20.22%
6m-10.09%
1yr+74.65%
Volume Change (%)
10d/3m+44.18%
Price vs... (%)
52w High-25.44%
50d MA+4.03%
200d MA+7.27%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)13.64
PEG Ratio (f)0.42
EPS Growth (f)47.51%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.96
Price to Tang. Book5.06
Price to Free Cashflown/a
Price to Sales5.99
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-29.42%
Return on Equity-0.87%
Operating Margin-38.3%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m26,57519,356.0515,372.5719,767.4629,904.8161,20094,500-0.92%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/a-2.95+111.96n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of L&K Biomed Co EPS forecast chart

Profile Summary

L&K BIOMED CO., LTD. is a Korea-based company mainly engaged in the research, development and manufacture of medical devices. The Company’s products consist of medical devices and medical equipment. Its medical devices include cervical spine products, such as cervical plate systems, cervical screw systems and cervical cage system, as well as thoracolumbar spine products and others. Its medical equipment includes three dimensional (3D) full-body scanners. It also engages in the bio-similar business, which develops cell engineering.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
December 22nd, 2008
Public Since
July 1st, 2013
No. of Shareholders
16,954
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
19,936,733
Blurred out image of a map
Address
301 475-42 Seogyo-dong, YONGIN, 17015
Web
http://www.lnkbiomed.com/
Phone
+82 267171911
Auditors
KPMG Samjong Accounting Corp

156100 Share Price Performance

Upcoming Events for 156100

Similar to 156100

Picture of Access Bio logo

Access Bio

kr flag iconKorea Exchange - KOSDAQ

Picture of Aligned Genetics logo

Aligned Genetics

kr flag iconKorea Exchange - KOSDAQ

Picture of Angel Robotics Co logo

Angel Robotics Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Asta Co logo

Asta Co

kr flag iconKorea Exchange - KOSDAQ

Picture of Biodyne Co logo

Biodyne Co

kr flag iconKorea Exchange - KOSDAQ

FAQ